dr. goldberg discusses resistance to egfr tki therapy in nsclc
Published 6 years ago • 138 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
6:03
managing resistance to egfr tkis in nsclc
-
1:41
dr. goldberg on resistance to osimertinib for nsclc
-
1:52
dr. goldberg discusses osimertinib in nsclc
-
1:16
dr. goldberg on options after developing resistance to osimertinib for nsclc
-
21:09
mechanisms of resistance to egfr tki and new treatment strategies
-
2:00
dr. goldberg on sequencing following treatment with osimertinib in nsclc
-
5:46
resistance mechanisms in egfr nsclc
-
1:47
dr. goldberg on further immunotherapy trials in non-small cell lung cancer
-
1:33
dr. yang on resistance mechanisms from osimertinib in nsclc
-
3:00
egfr-resistant disease in lung cancer
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
3:59
osimertinib for egfr t790m resistance mutations in nsclc
-
5:45
egfr tki sequencing
-
4:32
resistance mechanisms in egfr-positive nsclc
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
1:50
dr. goldberg on immune/targeted therapy combos in oncogene-driven lung cancer
-
1:31
dr. gold on the future of osimertinib in lung cancer
-
3:12
egfr-tki therapy in advanced nsclc
-
3:07
third generation egfr tkis for acquired resistance